IXHL vs LQDA

Incannex Healthcare Inc. vs Liquidia Corporation — Valuation Comparison 2026

IXHL

Drug Manufacturers - Specialty & Generic
Incannex Healthcare Inc.
Quality
5.3
out of 10
Value Trap
12
SAFE
Price
$3.55
Last close
Models
9/13
Active
VS

LQDA

Drug Manufacturers - Specialty & Generic
Liquidia Corporation
Quality
6.7
out of 10
Value Trap
24
SAFE
Price
$62.03
Last close
Models
13/13
Active

Model-by-Model Comparison

ModelType IXHL Fair ValueIXHL Upside LQDA Fair ValueLQDA Upside
Bayesian DCF Intrinsic $4.34 +22.2% $2.28 -96.3%
Earnings Power Value Intrinsic $5.66 -90.9%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $6.70 +88.8% $0.69 -98.9%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for IXHL vs LQDA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

IXHL vs LQDA — Which Stock Is More Undervalued?

LQDA scores higher with a 6.7/10 quality rating vs IXHL's 5.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Incannex Healthcare Inc. (IXHL) and Liquidia Corporation (LQDA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

IXHL currently trades at $3.55 with a QOC of 5.3/10, while LQDA trades at $62.03 with a QOC of 6.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).